Cargando…
A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment
BACKGROUND: Fluralaner (Bravecto®, Merck Animal Health, Madison, NJ, USA) is a novel isoxazoline that provides up to 12 weeks flea and tick control when administered orally to dogs. Two assessor-blinded studies, one in dogs, the other in cats evaluated the sustained efficacy of a topical fluralaner...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029119/ https://www.ncbi.nlm.nih.gov/pubmed/29970135 http://dx.doi.org/10.1186/s13071-018-2927-0 |
_version_ | 1783336897691516928 |
---|---|
author | Ranjan, Sivaja Young, David Sun, Fangshi |
author_facet | Ranjan, Sivaja Young, David Sun, Fangshi |
author_sort | Ranjan, Sivaja |
collection | PubMed |
description | BACKGROUND: Fluralaner (Bravecto®, Merck Animal Health, Madison, NJ, USA) is a novel isoxazoline that provides up to 12 weeks flea and tick control when administered orally to dogs. Two assessor-blinded studies, one in dogs, the other in cats evaluated the sustained efficacy of a topical fluralaner formulation against fleas in a simulated home environment (SHE). METHODS: Animals were ranked and blocked into groups of two using flea counts completed 24 hours following Ctenocephalides felis infestations placed on dogs on Day -64, and on cats on Day -36. Within blocks animals were randomized to a treatment group, 10 animals per group, one group to receive fluralaner spot-on (minimum dose rate for dogs, 25 mg/kg; for cats, 40 mg/kg), the other to be a sham-treated control. Animals were then placed into their SHE, one animal per pen or cage and then infested with 100 C. felis at weekly intervals. Dogs were infested from Day -56 through -21 and cats on Days -28 and -21. Fleas were counted and removed from each dog and cat on Day -1. Study animals were then held in clean pens/cages until treatment on Day 0. One day later, after treatment, all animals were returned to their home environment (SHE). Additional 50-flea challenges were placed on each animal on Days 22, 50 and 78. Fleas were counted and replaced on all animals on Day 1 and weekly thereafter for 12 weeks. RESULTS: Arithmetic mean counts in control-group animals exceeded 10 fleas at all post-treatment assessments except on Days 1, 7 and 14. All control-group animals remained infested at each assessment from Day or 28 through Day 84, thereby validating the challenge methodology. Fluralaner efficacy was 100% on all occasions except for 2 fleas found on 1 dog on Day 1, and 3 fleas on 1 dog on Day 14. One flea was recovered from 1 fluralaner treated cat on Day 1. There were no treatment-related adverse events. CONCLUSION: A single application of a topical formulation of fluralaner is well tolerated and highly effective in the prevention of flea infestations of dogs and cats throughout the 12 weeks following treatment. |
format | Online Article Text |
id | pubmed-6029119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60291192018-07-09 A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment Ranjan, Sivaja Young, David Sun, Fangshi Parasit Vectors Research BACKGROUND: Fluralaner (Bravecto®, Merck Animal Health, Madison, NJ, USA) is a novel isoxazoline that provides up to 12 weeks flea and tick control when administered orally to dogs. Two assessor-blinded studies, one in dogs, the other in cats evaluated the sustained efficacy of a topical fluralaner formulation against fleas in a simulated home environment (SHE). METHODS: Animals were ranked and blocked into groups of two using flea counts completed 24 hours following Ctenocephalides felis infestations placed on dogs on Day -64, and on cats on Day -36. Within blocks animals were randomized to a treatment group, 10 animals per group, one group to receive fluralaner spot-on (minimum dose rate for dogs, 25 mg/kg; for cats, 40 mg/kg), the other to be a sham-treated control. Animals were then placed into their SHE, one animal per pen or cage and then infested with 100 C. felis at weekly intervals. Dogs were infested from Day -56 through -21 and cats on Days -28 and -21. Fleas were counted and removed from each dog and cat on Day -1. Study animals were then held in clean pens/cages until treatment on Day 0. One day later, after treatment, all animals were returned to their home environment (SHE). Additional 50-flea challenges were placed on each animal on Days 22, 50 and 78. Fleas were counted and replaced on all animals on Day 1 and weekly thereafter for 12 weeks. RESULTS: Arithmetic mean counts in control-group animals exceeded 10 fleas at all post-treatment assessments except on Days 1, 7 and 14. All control-group animals remained infested at each assessment from Day or 28 through Day 84, thereby validating the challenge methodology. Fluralaner efficacy was 100% on all occasions except for 2 fleas found on 1 dog on Day 1, and 3 fleas on 1 dog on Day 14. One flea was recovered from 1 fluralaner treated cat on Day 1. There were no treatment-related adverse events. CONCLUSION: A single application of a topical formulation of fluralaner is well tolerated and highly effective in the prevention of flea infestations of dogs and cats throughout the 12 weeks following treatment. BioMed Central 2018-07-03 /pmc/articles/PMC6029119/ /pubmed/29970135 http://dx.doi.org/10.1186/s13071-018-2927-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Ranjan, Sivaja Young, David Sun, Fangshi A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment |
title | A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment |
title_full | A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment |
title_fullStr | A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment |
title_full_unstemmed | A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment |
title_short | A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment |
title_sort | single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029119/ https://www.ncbi.nlm.nih.gov/pubmed/29970135 http://dx.doi.org/10.1186/s13071-018-2927-0 |
work_keys_str_mv | AT ranjansivaja asingletopicalfluralanerapplicationtocatsandtodogscontrolsfleasfor12weeksinasimulatedhomeenvironment AT youngdavid asingletopicalfluralanerapplicationtocatsandtodogscontrolsfleasfor12weeksinasimulatedhomeenvironment AT sunfangshi asingletopicalfluralanerapplicationtocatsandtodogscontrolsfleasfor12weeksinasimulatedhomeenvironment AT ranjansivaja singletopicalfluralanerapplicationtocatsandtodogscontrolsfleasfor12weeksinasimulatedhomeenvironment AT youngdavid singletopicalfluralanerapplicationtocatsandtodogscontrolsfleasfor12weeksinasimulatedhomeenvironment AT sunfangshi singletopicalfluralanerapplicationtocatsandtodogscontrolsfleasfor12weeksinasimulatedhomeenvironment |